Newsletter Signup | Join Community
118
2
Genomic testing should be performed in all patients-precision medicines reduce recurrences and prolong survival.
Keytruda immunotherapy + BRAF- MEK Inhibitors combo further delays melanoma progression compared BRAF-MEK alone.
Keytruda treatment for melanoma improves survival, treats CNS disease and may be most effective when used in combination
BRAF-MEK combination improves survival in stage III and advanced melanoma with V600E and V600K mutations
Opdivo anti-PD-1 immunotherapy can be used to treat both stage III and more advanced melanoma.
Regular use of sunscreen may help prevent melanoma. These findings were reported in the Journal of Clinical Oncology.
Treatment of anti-PD-1 resistant melanomas with Entinostat and APX005M
Anyone have experience with TVEC? Looking to learn from others. Thanks
A new very active treatment option for Melaoma-Braftovihttps://mavendoctors…
